4. 5 Interaktion med andre lægemidler og andre former for interaktion).
20 mg every second day) should be considered in patients with hepatic impairment (see 5.2 Pharmacokinetic properties), or in patients where concomitant medication has the potential for interaction with (Invented name)® (see 4.5 Interactions).